Tenderwize
Zurück zur Suche

Fentanyl medicines excluding matrix patches and tablets

AOK Sachsen - Anhalt·Magdeburg, Germany·Deadline Dec 30, 2027 · 491 days left·Open·Supplies
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Fentanyl (ATC: N02AB03 - außer Matrixpflaster und Tabletten)

58/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Warum diese Bewertung?

Chance

58 / 100

Komplexität

42 / 100

Risikofaktoren

The structured data says electronic submission is not allowed, but the XML text says signed contract documents may be s...

The structured deadline is 2027-12-30T23:00:00Z, while the XML notice shows an end date of 2027-12-31 00:00:00+01:00.

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Supplies contract
  • 1 lot
  • Duration 2 YEAR
  • Non-exclusive rebate agreements for pharmaceutical products containing fentanyl.
  • Open-house model with uniform contract terms and equal access for all qualified applicants.
Vollständige Zusammenfassung anzeigen

This is an open-house style notice for non-exclusive rebate agreements for pharmaceutical products containing fentanyl (ATC N02AB03, excluding matrix patches and tablets) with AOK Sachsen-Anhalt. The structured data indicates one lot, no estimated contract value, and a 2-year maximum term. The notice states that qualified pharmaceutical companies may join at any time under identical conditions, with no individual negotiations. Submission is not allowed electronically in the structured data, but the XML text also mentions postal submission and email transmission of signed contract documents, creating an inconsistency that should be clarified.

Risiken

The structured data says electronic submission is not allowed, but the XML text says signed contract documents may be s...

The structured deadline is 2027-12-30T23:00:00Z, while the XML notice shows an end date of 2027-12-31 00:00:00+01:00.

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Applicant must be a pharmaceutical company or a group of pharmaceutical companies.
  • The notice states that only companies meeting the participation requirements will be contracted.

Administrative

  • Participation documents must be requested and then completed and signed in full.

Auftraggeber

Ort

Magdeburg, DEU

Auftraggeberprofil

Profil öffnen

Kennung

DE258393558

Tätigkeit

Health

Lose (1)

LOT-0001

Fentanyl medicines excluding matrix patches and tablets

Open-house rebate agreement for finished medicinal products containing fentanyl (ATC N02AB03), excluding matrix patches and tablets. The lot is for non-exclusive contracts under uniform conditions; any qualified pharmaceutical company may join. The contract can start from 2026-03-01 at the earliest and ends on 2028-02-29 regardless of start date. The XML text also mentions that signed contract documents may be sent by post or by email with a qualified electronic signature.

SuppliesEU fundedElectronic submission

Ort

DEE03, Germany

Dauer

2 YEAR

Kategorie

Pharmaceutical products

Frist

Deadline Dec 30, 2027

Vergabedetails

Veröffentlichungsdatum
16 Dec 2025
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
840297-2025

Dokumente (1)

Ähnliche Ausschreibungen